Skip to content

Investigational protease inhibitor TMC310911 highly potent in phase 2 study

Sofosbuvir + ribavirin for 24 weeks is highly effective against HCV genotype 4

Early antiretroviral treatment reduces risk of AIDS and HIV-related illness

PCR testing reveals high prevalence of CNS infections among people living with HIV in Zambia with CNS symptoms

Methadone and buprenorphine-naloxone both associated with reduced HIV risk among people who inject drugs

Implementation of a comprehensive harm reduction programme curtailed the HIV epidemic among people who inject drugs in Taiwan

HIV infection increases risk of melanoma

Three-drug AbbVie combination safe and highly effective in treatment of post-transplant hepatitis C recurrence

Sofosbuvir for hepatitis C works well despite multiple negative predictive factors

Graham Foster speaking at the International Liver Congress 2014. Photo by Liz Highleyman, hivandhepatitis.com.